This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Gary Strichartz: Innovating Local Anesthetic Formulations
Introduction
Gary Strichartz, an influential inventor based in Sherborn, MA, has made significant contributions to the field of medicinal chemistry, particularly in the development of local anesthetic formulations. With one patent to his name, he has focused on enhancing the safety, specificity, and duration of nerve blocks through innovative combinations of naturally occurring sodium channel blockers and other agents.
Latest Patents
Gary's patented work centers around local anesthetic formulations that utilize combinations of naturally occurring site 1 sodium channel blockers, including tetrodotoxin (TTX), saxitoxin (STX), decarbamoyl saxitoxin, and neosaxitoxin. These toxins have been combined with local anesthetics, vasoconstrictors, glucocorticoids, and adrenergic drugs to achieve prolonged and effective nerve block. Noteworthy embodiments of his invention highlight the use of amphiphilic or lipophilic solvents that enhance the duration of nerve blocks, alongside advancements in microencapsulation techniques utilizing biodegradable synthetic polymeric carriers.
Career Highlights
Throughout his career, Gary Strichartz has been dedicated to advancing the science of pain management through research and innovation. His patented formulation reflects a deep understanding of pharmacology and a commitment to improving patient care outcomes. Gary's work stands out for its focus on both efficacy and safety in local anesthesia.
Collaborations
Strichartz has collaborated with notable figures in the field, including Daniel S. Kohane and Charles B. Berde. Together, they have worked on various aspects of pain management, contributing to a collaborative approach that merges their expertise for greater innovations in medical treatments.
Conclusion
In summary, Gary Strichartz is a remarkable inventor whose contributions to local anesthetic formulations have the potential to make significant impacts on medical practices. His innovative approaches reflect a commitment to safety and efficacy, setting the stage for future advancements in pain management. Through his patent and collaborative efforts, he continues to inspire progress in the field of anesthesiology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile